GSE126463 pomalidomide MM1.S 4 v 3 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE126463_pomalidomide_MM1.S_4_v_3_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE126463_pomalidomide_MM1.S_4_v_3_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE126463_pomalidomide_MM1.S_4_v_3_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE126463_pomalidomide_MM1.S_4_v_3_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

Rho GTPase activating protein 23

Gene

NBPF member 8

Gene

CDGSH iron sulfur domain 3

Gene

long intergenic non-protein coding RNA 3040

Gene

long intergenic non-protein coding RNA 3219

Gene

miR-17-92a-1 cluster host gene

Gene

VIM antisense RNA 1

Gene

CEP192 pseudogene 1

Gene

solute carrier family 7 member 5 pseudogene 1

Gene

uncharacterized LOC102724684

  • Gene

    Rho GTPase activating protein 23



  • Gene

    CDGSH iron sulfur domain 3


  • Gene

    long intergenic non-protein coding RNA 3040


  • Gene

    long intergenic non-protein coding RNA 3219


  • Gene

    miR-17-92a-1 cluster host gene


  • Gene

    VIM antisense RNA 1


  • Gene

    CEP192 pseudogene 1


  • Gene

    solute carrier family 7 member 5 pseudogene 1


  • Gene

    uncharacterized LOC102724684

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.